Randomized phase 3 study in low-grade lymphoma comparing maintenance anti-CD20 antibody with observation after induction therapy: A trial of the ECOG-ACRIN cancer research group (E1496)

Stefan K. Barta, Hailun Li, Howard S. Hochster, Fangxin Hong, Edie Weller, Randy D. Gascoyne, Thomas M. Habermann, Leo I. Gordon, Natalia Colocci, Elizabeth M. Bengtson, Sandra J. Horning, Brad S. Kahl

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized phase 3 study in low-grade lymphoma comparing maintenance anti-CD20 antibody with observation after induction therapy: A trial of the ECOG-ACRIN cancer research group (E1496)'. Together they form a unique fingerprint.

Medicine & Life Sciences